Exosome therapy for childhood autism study
Part of Mental health clinical trials.
This trial tests if exosomes from stem cells can help children with autism who haven't improved enough with standard behavioral therapy. It aims to see if this treatment is safe and effective for reducing autism symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child has a confirmed diagnosis of autism spectrum disorder (ASD) using standard criteria.
- Child has not shown much improvement after at least 3 months of standard behavioral therapy.
- Child scores 30 or higher on a test that measures autism severity (CARS2), meaning mild-to-moderate or more severe autism.
- Child is between 3 and 7 years old, including ages 3 and 7.
- Parent or legal guardian agrees to the study and signs a consent form.
- Child is willing to undergo all tests, treatments, and follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of experimental treatments for children with autism spectrum disorder. It may help if your child has not had stem cell or glutathione therapy before.
This is an early-stage study exploring a new experimental treatment for autism spectrum disorder (ASD). Researchers will work with your child and family to test whether this approach is safe and how it might help with autism symptoms.
This study combines three treatments—light therapy at acupoints, your child's own platelet-rich plasma, and umbilical cord exosomes—to see if they can help improve symptoms of autism spectrum disorder. It's for children ages 3 to 12 with an autism diagnosis, and you'll work closely with the study team.
This trial tests whether stem cells from donated umbilical cord tissue can help children with autism. It is for children aged 4–14 who weigh at least 10 kg and are otherwise healthy.
This trial tests a stem cell treatment for children and adults with Autism Spectrum Disorder. It aims to see if this treatment is safe and if it can help improve autism symptoms.
This trial tests a new drug made from stem cell exosomes (CB-Exo-A600) to see if it can help people with mild to moderate Alzheimer's disease. It aims to slow down symptoms and improve quality of life.
Hear when a new Prospective Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.